Dividend Talk

EP #166 | Navigating the Current Market and Our Q3 Portfolio Performance | What about NN Group and ASR Netherlands?

Oct 7, 2023
In this podcast, the hosts discuss the NN Group court ruling and its potential impact on dividends. They also analyze the challenges faced by Walmart and consumer staple stocks due to weight-loss drug concerns. The FDA's scrutiny of Philips' respiratory devices is explored, along with the rumors of Exxon's acquisition of Pioneer Natural Resources. The hosts dissect current market conditions and strategies for navigating them. They review their Q3 portfolio performance and discuss the importance of balance sheets and dollar-cost averaging. Insider buying and selling, price to book value, and following famous investors are dismissed as factors in investment decisions. McDonald's long-term potential, Agio, and Pernod Ricard are also discussed. The hosts analyze various dividend-paying companies, their reliability, and potential investments like American Express, American Tower, and UPS. The challenges of obtaining a residence certificate and tax paperwork are explored, and an apology is made for missing a week.
Ask episode
Chapters
Transcript
Episode notes